Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A
Maryam Pourmaleki, Jonathan H. Young, Nicholas D. Socci, et al.
Oncotarget (2019) Vol. 10, Iss. 58, pp. 6152-6167
Open Access | Times Cited: 16

Showing 16 citing articles:

Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments
Shoichiro Ishizuki, Yoshiyuki Nakamura
Current Oncology (2021) Vol. 28, Iss. 4, pp. 2969-2986
Open Access | Times Cited: 80
The emerging and challenging role of PD-L1 in patients with gynecological cancers: An updating review with clinico-pathological considerations
Angela Santoro, Giuseppe Angelico, Frediano Inzani, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 57-66
Open Access | Times Cited: 13
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
Fulvio Borella, Mario Preti, Luca Bertero, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 190-190
Open Access | Times Cited: 39
Mapping the potential for anti-PD-1 therapy in advanced rare skin carcinomas
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity
Jesús Chamorro Pérez, Alfonso Cortés, Belén Perez‐Mies, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 10, pp. 1081-1094
Open Access | Times Cited: 9
Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report
Brendan J. Guercio, Gopa Iyer, Wajih Zaheer Kidwai, et al.
Case Reports in Oncology (2021) Vol. 14, Iss. 1, pp. 430-438
Open Access | Times Cited: 20
KCNQ1OT1 sponges miR‐34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD‐L1 axis
Xin Wang, Zhiyao Ren, Yunfeng Xu, et al.
Environmental Toxicology (2022) Vol. 38, Iss. 2, pp. 368-380
Closed Access | Times Cited: 10
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
Emma Zattarin, Federico Nichetti, Francesca Ligorio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network
Mintao Xiao, Chunrong Pang, Shixin Xiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
B7 immune checkpoint family members as putative therapeutics in autoimmune disease: An updated overview
Katayoun Dolatkhah, Nazila Alizadeh, Hanieh Mohajjel‐Shoja, et al.
International Journal of Rheumatic Diseases (2022) Vol. 25, Iss. 3, pp. 259-271
Closed Access | Times Cited: 7
Programmed Death-Ligand 1 and Programmed Death-Ligand 2 Expression Can Affect Prognosis in Extramammary Paget’s Disease
Aya Kawaguchi, Jun Akiba, Reiichiro Kondo, et al.
Anticancer Research (2021) Vol. 41, Iss. 1, pp. 219-226
Open Access | Times Cited: 6
Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature
Xin Yin, Xiaoqing Li, Muli Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Expression of programmed cell death ligand 1 (PD‐L1) at in situ and invasive extramammary Paget’s disease and literature review
Junji Kato, Shintaro Sugita, Kohei Horimoto, et al.
Australasian Journal of Dermatology (2021) Vol. 62, Iss. 3, pp. 412-414
Closed Access | Times Cited: 5
Molecular Features of Preinvasive and Invasive Vulvar Neoplasms
Pratik Q. Deb, Debra S. Heller
Journal of Lower Genital Tract Disease (2022) Vol. 27, Iss. 1, pp. 40-46
Closed Access | Times Cited: 2
PD-1 Signaling in Extramammary Paget Disease
Mohammed Dany
Cutis (2020) Vol. 105, Iss. 6
Open Access | Times Cited: 1
The Co-Expression of Melanoma-Antigen Family a Proteins and New York Esophageal Squamous Cell Carcinoma-1 in Breast Cancer: A Pilot Study
Yuxin Wang, Fenglian Li, Li-Xin Du, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 6123-6128
Open Access
Page 1

Scroll to top